Location: Home
  • search
  • go
  • Relate News
  • 12/29/2023Drug R&D and Product Registration News Digest December 2023 (4)
  • 12/29/2023Financial-related Company News Digest (December 2023)
  • 12/29/2023China Issues the Implementation Plan for Saving Drug Resources and Cur...
  • 12/28/2023Astellas and Elpiscience Enter Research and License Deal for Novel Bis...
  • 12/28/2023CDE Issues the Technical Guidelines for Clinically Relevant Communicat...
  • 12/28/2023China's Revised Measures for the Administration and Registration of Fo...
  • 12/27/2023Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win (Se...
  • 12/27/2023vTv Therapeutics Received Notice from Huadong Pharma for Termination o...
  • 12/27/2023Innovent and Xuanzhu Enter into Clinical Trial Collaboration for Combo...
  • 12/26/2023NMPA Solicits Comments on the Draft of GMP's Blood Product Appendix
  • 12/26/2023NHC Issues the 3rd Batch of Its Catalogue of Encouraged Generic Drugs
  • 12/26/2023AstraZeneca to Buy Gracell to Further Cell Therapy Ambition Across Onc...
  • 12/26/2023NMPA Issues the List of Reference Formulations for GQCE Studies (74th ...
  • 12/26/2023LianBio Licenses Its Rights for NBTXR3 in China and Other Asian Marke...
  • 12/26/2023China Issues Guidance Policy for High-Quality Development of Disease...
  • 12/26/20232024 Forecast: Big Pharma Reworks China Strategy, And Job Cuts Are Par...
  • 12/25/2023NHC Claims Occupational Health Improvements
  • 12/25/2023Mitsubishi Tanabe Sells Majority Stake of Chinese JV to Local Partner ...
  • 12/25/2023NMPA Solicits Comments on the Implementation Doc for Provisions for QC...
  • 12/25/2023GeneQuantum and BioMap Strikes Strategic Deal to Jointly Develop Next...
  • 12/25/2023Oncoshot Teams Up with Zhejiang Ablaze Medicine to Drive Data-Powered ...
  • 12/25/2023InxMed Enters License Agreement with Escugen to Develop Next-Generatio...
  • 12/25/2023Biocytogen Enters into Antibody Deal with Ona Therapeutics to Develop ...
  • 12/25/2023Qilu Pharma Acquires Hyperlipidemia Drug Candidate RBD7022 from Ribo...
  • 12/22/2023State Council Issues Amended Implementing Regulations of the Chinese P...
  • 12/22/2023China to Slash Import Tax on Some Anticancers and Rare Disease Drugs N...
  • 12/22/2023CDE Solicits Comments on the Dossier Requirements for Marketing Regist...
  • 12/22/2023Drug R&D and Product Registration News Digest December 2023 (3)
  • 12/21/2023Servier Acquires Rights to TIBSOVO® in Greater China and Singapore fr...
  • 12/20/2023GSK Enters Exclusive License Agreement with Hansoh for ADC HS-20093
  • Page:120/816 Total number of articles:24465: [First][<<] [118] [119] [120] [121] [122] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group